Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer

NCT04498689 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: Camrelizumab
DRUG: Nab paclitaxel
DRUG: Gemcitabine Injection

Sponsor

Fudan University